Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bliss Properti Indonesia Tbk. (POSA) vs Organon Pharma Indonesia Tbk. (SCPI)

Bliss Properti Indonesia Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bliss Properti Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Bliss Properti Indonesia Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 419,44 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bliss Properti Indonesia Tbk. jauh lebih besar — sekitar 4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

POSASCPI
Kapitalisasi Pasar
419,44 M104,4 M

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

POSA
Lihat detail
SCPI
Lihat detail

Tentang Bliss Properti Indonesia Tbk.

PT Bliss Properti Indonesia ("the Company") was established based on deed No. 4 dated May 14, 2010 of Sri Eliana Tjahjoharto, S.H., notary in Surabaya. The Company belong to group of companies owned by Posa Group.

Selengkapnya di halaman POSA

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI